Bassel F. El‐Rayes

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim et al. · JAMA Oncology · 2020 · 1.2K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +15

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma

Vincenzo Mazzaferro, Bassel F. El‐Rayes, Michele Droz Dit Busset et al. · British Journal of Cancer · 2018 · 380 citations · Full text

Medicine, Oncology, Pharmacology +17

Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Charles A. Schiffer, Pamela B. Mangu, James C. Wade et al. · Journal of Clinical Oncology · 2013 · 361 citations

Medicine, Oncology, Surgery +17

Nivolumab (NIVO) + ipilimumab (IPI) combination therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC): Results from CheckMate 040.

Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim et al. · Journal of Clinical Oncology · 2019 · 230 citations

Medicine, Oncology, Pharmacology +15

CheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis

Masatoshi Kudo, Ana Matilla, Armando Santoro et al. · Journal of Hepatology · 2021 · 226 citations · Full text

Medicine, Oncology, Pharmacotherapy +15